Castle Biosciences (CSTL) Other financing activities (2021)

Castle Biosciences' (CSTL) quarterly Other financing activities came in at $336000.0 in Q1 2021.

Castle Biosciences (CSTL) Other financing activities (2021) Analysis & Trends

Castle Biosciences has disclosed Other financing activities across 1 years of filings, most recently posting $336000.0 for Q1 2021.

  • Other financing activities for Q1 2021 came in at $336000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2021 was $336000.0 (changed N/A YoY), and the FY2021 annual result was $336000.0, changed N/A from the prior year.
  • Other financing activities came in at $336000.0 for Q1 2021 at Castle Biosciences.
  • In the past five years, Other financing activities ranged from a high of $336000.0 in Q1 2021 to a low of $336000.0 in Q1 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Waters 30,529.42 Bn 30,528.96 Bn 1.11 Bn
2 Thermo Fisher Scientific 183.75 Bn 180.50 Bn 7.74 Bn
3 Danaher 133.13 Bn 127.43 Bn 3.59 Bn
4 Idexx Laboratories 46.14 Bn 45.94 Bn 722.74 Mn
5 Agilent Technologies 38.20 Bn 36.39 Bn 990.00 Mn
6 Natera 31.50 Bn 30.40 Bn 696.04 Mn
7 Iqvia Holdings 31.34 Bn 29.36 Bn 1.36 Bn
8 Illumina 24.51 Bn 23.36 Bn 721.00 Mn
9 Mettler Toledo International 23.53 Bn 23.47 Bn 555.82 Mn
10 Castle Biosciences 629.76 Mn 368.04 Mn 63.15 Mn

Historic Data

Download Data
DateValue
Mar 31, 2021 336,000.00
Mar 31, 2021 336,000.00